Attorneys for Bard, Endo Health Solutions, Inc., Boston Scientific Corp., Coloplast A/S and Cook Medical, Inc., all manufacturers of transvaginal mesh implants, are in settlement talks over literally thousands of lawsuits, say sources familiar with the cases. Transvaginal mesh is used to support women’s pelvic muscles during stress urinary incontinence (SUI) and pelvic organ prolapse (POP) surgeries. Plaintiffs allege to have experienced severe emotional and physical damage from these implants after surgery . Johnson & Johnson is also facing countless lawsuits but isn’t involved in these talks, according to sources.
Plaintiffs’ attorneys are requesting that U.S. District Judge Joseph Goodwin (the judge overseeing these federal lawsuits) appoint a settlement committee. The talks are designed to resolve over 30,000 suits that have been consolidated for pre-trial information exchanges. The number of suits may rise to as many as 50,000 as more women seek to participate in what could be a multi-billion dollar settlement.
Some manufacturers such as Bard and Endo have already settled lawsuits over these implants. In fact, earlier this year, Endo officials paid $54.5 million in settlements over their defective devices.
Bard removed its Avaulta implants off the market last year after the Food and Drug Administration mandated that all manufacturers of these devices perform studies on organ damage, infection and pain during intercourse linked to erosion of the mesh after surgeries, often resulting in additional surgeries to attempt removal of these devices.
More information will follow as we learn more about these potential settlements. Stay tuned to the Reyes Browne Reilley Dallas personal injury attorney law blog, or call us at 877-308-7900 for the latest transvaginal mesh case updates.
This post is also available in: Spanish